Important:

Use our online services for all queries and prescriptions (click here) If you believe you will need to be seen on the same day then please submit your form as early as possible on that day.

Mounjaro and other weight loss medication requests

Mounjaro and other weight loss medication requests

To get Mounjaro (tirzepatide) on the NHS for weight loss, you need a BMI of 35 or more (adjusted for ethnicity) and a diagnosis of at least four of these conditions: Type 2 diabetes, high blood pressure, heart disease, obstructive sleep apnoea, or abnormal blood fats (dyslipidaemia).

Who is eligible?

  • BMI: 35+ (or 32.5+ for Black, Asian, and other minority ethnic backgrounds).
  • Co-morbidities: At least four of the following diagnosed conditions:

If you think you may be eligible for this service based on the above, please submit a request via the practice website
We will review your records to confirm whether you meet the criteria. If you do, we will arrange an appropriate appointment with our team to discuss. Please note:

  • The practice does not have any role in monitoring patients who are getting Mounjaro privately (ie not on the NHS)

 

If you would be interested in other weight loss management then there are several options

Tier 2 is self referral to Beezee where there are several options: Beezee Oxfordshire - Free Healthy Lifestyle Programmes

You can also look at other local options using this link to local services: Search results | Oxfordshire MarketPlace

 

Tier 3 is GP referral only, not provided locally, and the criteria are very restrictive – if you fit the criteria then please book a routine appointment to discuss the referral with one of the clinical team, this could be a nurse, pharmacist or GP.

NOTE – this is not a local service, it is commissioned by Oxfordshire but based in Bedfordshire hospitals.  For further information, including referral criteria, updates on waiting times and access to NHS weight loss medication, please visit their website: http://www.bedfordshirehospitals.nhs.uk/bariatrics/gp-hub

 

New Semaglutide (Wegovy) Tablet Approved – Not Available on the NHS
The MHRA has approved the first GLP‑1 tablet (semaglutide) for weight loss and weight management in the UK. This is a once‑daily tablet licensed for adults with obesity or those who are overweight with a weight‑related health condition.

At present, this medication is not available through the NHS, and GP practices cannot prescribe it. Please do not contact the practice to request a prescription, as we are unable to issue it.

Patients seeking support with weight management can discuss existing NHS‑approved options with our clinical team.